JP2018000080A - 葉酸の安定性が優れた葉酸含有酸性組成物 - Google Patents
葉酸の安定性が優れた葉酸含有酸性組成物 Download PDFInfo
- Publication number
- JP2018000080A JP2018000080A JP2016130217A JP2016130217A JP2018000080A JP 2018000080 A JP2018000080 A JP 2018000080A JP 2016130217 A JP2016130217 A JP 2016130217A JP 2016130217 A JP2016130217 A JP 2016130217A JP 2018000080 A JP2018000080 A JP 2018000080A
- Authority
- JP
- Japan
- Prior art keywords
- folic acid
- less
- composition
- acid
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 189
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 96
- 239000011724 folic acid Substances 0.000 title claims abstract description 96
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 95
- 229960000304 folic acid Drugs 0.000 title claims abstract description 95
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 230000002378 acidificating effect Effects 0.000 title claims abstract description 42
- 239000003960 organic solvent Substances 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 96
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 235000015110 jellies Nutrition 0.000 claims description 6
- 239000008274 jelly Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 abstract description 11
- 125000003929 folic acid group Chemical group 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 239000003205 fragrance Substances 0.000 description 16
- 235000013305 food Nutrition 0.000 description 14
- 238000003860 storage Methods 0.000 description 13
- 235000013361 beverage Nutrition 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- -1 pH adjusters Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 240000002234 Allium sativum Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 150000001559 benzoic acids Chemical class 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SYEYEGBZVSWYPK-UHFFFAOYSA-N 2,5,6-triamino-4-hydroxypyrimidine Chemical compound NC1=NC(N)=C(N)C(O)=N1 SYEYEGBZVSWYPK-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000000716 Durio zibethinus Species 0.000 description 1
- 235000006025 Durio zibethinus Nutrition 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000002307 glutamic acids Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
[1] 葉酸を含有する酸性組成物であって、プロトン性有機溶媒の含有量が0.1重量%未満であることを特徴とする、組成物。
[2] プロトン性有機溶媒がエタノール、グリセリン、メタノール、酢酸、ギ酸、ブチルアミンである、[1]の組成物。
[3] 容器詰め飲料又は容器詰めゼリー飲料である、[1]又は[2]の組成物。
[4] 葉酸を含有する酸性組成物の製造方法であって、プロトン性有機溶媒の配合量が0.1重量%未満となるように原材料を配合することを含む、方法。
[5] 酸性組成物中における葉酸の安定性を向上させる方法であって、該組成物中に含まれるプロトン性有機溶媒の量を0.1重量%未満とすることを含む、方法。
[6] プロトン性有機溶媒がエタノール、グリセリン、メタノール、酢酸、ギ酸、ブチルアミンである、[4]又は[5]の方法。
[7] 酸性組成物が容器詰め飲料又は容器詰めゼリー飲料である、[4]〜[6]のいずれかの方法。
1.標準原液
葉酸100mgを200mL褐色ビーカーに精秤し、0.1N水酸化ナトリウム溶液(和光純薬)を5mL添加して溶解した。次いで、特級エタノール(和光純薬)10mLを添加・混和後、イオン交換水100mLと0.1N塩酸(和光純薬)にて溶液のpHを7.0〜8.0に調整した。200mL褐色メスフラスコとイオン交換水を用いて所定量に定容し、HPLC測定における検量線作成のための標準原液とした。
葉酸を含む溶液サンプルは、重量を測定後、1.0N水酸化ナトリウム溶液(和光純薬)を用いてpH12.0(HORIBA製pHメーター(F−72))に調整した。次いで、10分間撹拌後(AS ONE製マグネティックスターラー(RSH−1AN))、1.0N塩酸(和光純薬)を用いてpH7.0に調整し、ろ過し(AS ONE製0.45μmフィルター(SY25TF))、得られたろ液をHPLC測定に付した。
HPLC測定は、以下の条件にて実施した。
カラム:Waters XBridge C18 5μm 6×250mm
温度:50℃
流量:1.2ml/min
移動相:12%メタノール(和光純薬)、0.3%酢酸(和光純薬)、1.08%オクタスルホン酸Na溶液(和光純薬)
イオン交換水にグラニュー糖2.5重量%、果糖1.2重量%、L−アスコルビン酸0.8重量%、クエン酸0.2重量%、クエン酸三ナトリウム0.2重量%、及び葉酸0.0003重量%を添加し、1.0N塩酸(和光純薬)、及び1.0N水酸化ナトリウム(和光純薬)を用いて、所定のpHに調整し、ベース液とした。
下記表1に示す組成にしたがって、ベース液、ならびに、エタノール、又は、アセトニトリルを含み、所定のpHを有する溶液(実施例1〜7、比較例1E〜7E(エタノール添加)、比較例1A〜7A(アセトニトリル添加))をそれぞれ調製した(0日目)。
下記表3に示す組成にしたがって、ベース液、及びエタノールを含み、pHを3.5とする溶液(実施例8、9、比較例8E)をそれぞれ調製した(0日目)。
下記表5に示す組成にしたがって、葉酸を含む溶液(実施例10、比較例9E)をそれぞれ調製した(0日目)。なお、香料1はエタノールを含まず中鎖脂肪酸とグリセリン脂肪酸エステルを溶媒として用いて、溶液化した香料であり、香料2は溶媒としてエタノールを50重量%(最終製品濃度0.1重量%)含む香料である。
Claims (7)
- 葉酸を含有する酸性組成物であって、プロトン性有機溶媒の含有量が0.1重量%未満であることを特徴とする、組成物。
- プロトン性有機溶媒がエタノール、グリセリン、メタノール、酢酸、ギ酸、ブチルアミンである、請求項1に記載の組成物。
- 容器詰め飲料又は容器詰めゼリー飲料である、請求項1又は2に記載の組成物。
- 葉酸を含有する酸性組成物の製造方法であって、プロトン性有機溶媒の配合量が0.1重量%未満となるように原材料を配合することを含む、方法。
- 酸性組成物中における葉酸の安定性を向上させる方法であって、該組成物中に含まれるプロトン性有機溶媒の量を0.1重量%未満とすることを含む、方法。
- プロトン性有機溶媒がエタノール、グリセリン、メタノール、酢酸、ギ酸、ブチルアミンである、請求項4又は5に記載の方法。
- 酸性組成物が容器詰め飲料又は容器詰めゼリー飲料である、請求項4〜6のいずれか一項に記載の方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016130217A JP6862108B2 (ja) | 2016-06-30 | 2016-06-30 | 葉酸の安定性が優れた葉酸含有酸性組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016130217A JP6862108B2 (ja) | 2016-06-30 | 2016-06-30 | 葉酸の安定性が優れた葉酸含有酸性組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021009980A Division JP7201142B2 (ja) | 2021-01-26 | 2021-01-26 | 葉酸の安定性が優れた葉酸含有酸性組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018000080A true JP2018000080A (ja) | 2018-01-11 |
JP6862108B2 JP6862108B2 (ja) | 2021-04-21 |
Family
ID=60945409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016130217A Active JP6862108B2 (ja) | 2016-06-30 | 2016-06-30 | 葉酸の安定性が優れた葉酸含有酸性組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6862108B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108902575A (zh) * | 2018-07-24 | 2018-11-30 | 河北冀衡(集团)药业有限公司 | 饮料及其制备方法 |
WO2019130499A1 (ja) * | 2017-12-25 | 2019-07-04 | ハウスウェルネスフーズ株式会社 | ビタミンb群化合物の安定性が優れたビタミンb群化合物含有酸性組成物 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900416A (en) * | 1996-02-01 | 1999-05-04 | Anthea Enterprises Incorporated | Aqueous caffeine dosage forms |
JP2001238640A (ja) * | 2000-02-28 | 2001-09-04 | Snow Brand Milk Prod Co Ltd | 葉酸及び/又はビタミンb12−ラクトフェリン類複合物 |
JP2006254871A (ja) * | 2005-03-18 | 2006-09-28 | Ito En Ltd | コエンザイムq10含有飲料 |
JP2006342061A (ja) * | 2005-06-07 | 2006-12-21 | Nikken Kasei Kk | ミネラル含有水溶液組成物 |
JP2011055828A (ja) * | 2009-08-12 | 2011-03-24 | Taisho Pharmaceutical Co Ltd | 葉酸含有飲料 |
JP5000770B1 (ja) * | 2011-01-27 | 2012-08-15 | 長谷川香料株式会社 | ワサビ風味増強剤、ワサビ香料組成物および飲食品のワサビ風味増強方法。 |
JP2015174915A (ja) * | 2014-03-14 | 2015-10-05 | 長谷川香料株式会社 | 香料含有顆粒状組成物の製造方法 |
JP2015529448A (ja) * | 2012-06-27 | 2015-10-08 | ディーエスエム アイピー アセッツ ビー.ブイ. | 水溶性活性成分を含むナノゲル |
JP2015193579A (ja) * | 2014-03-31 | 2015-11-05 | 小林製薬株式会社 | ゼラチンカプセル剤およびその製造方法 |
WO2016084887A1 (ja) * | 2014-11-27 | 2016-06-02 | 大正製薬株式会社 | 水性液体飲料 |
-
2016
- 2016-06-30 JP JP2016130217A patent/JP6862108B2/ja active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900416A (en) * | 1996-02-01 | 1999-05-04 | Anthea Enterprises Incorporated | Aqueous caffeine dosage forms |
JP2001238640A (ja) * | 2000-02-28 | 2001-09-04 | Snow Brand Milk Prod Co Ltd | 葉酸及び/又はビタミンb12−ラクトフェリン類複合物 |
JP2006254871A (ja) * | 2005-03-18 | 2006-09-28 | Ito En Ltd | コエンザイムq10含有飲料 |
JP2006342061A (ja) * | 2005-06-07 | 2006-12-21 | Nikken Kasei Kk | ミネラル含有水溶液組成物 |
JP2011055828A (ja) * | 2009-08-12 | 2011-03-24 | Taisho Pharmaceutical Co Ltd | 葉酸含有飲料 |
JP5000770B1 (ja) * | 2011-01-27 | 2012-08-15 | 長谷川香料株式会社 | ワサビ風味増強剤、ワサビ香料組成物および飲食品のワサビ風味増強方法。 |
JP2015529448A (ja) * | 2012-06-27 | 2015-10-08 | ディーエスエム アイピー アセッツ ビー.ブイ. | 水溶性活性成分を含むナノゲル |
JP2015174915A (ja) * | 2014-03-14 | 2015-10-05 | 長谷川香料株式会社 | 香料含有顆粒状組成物の製造方法 |
JP2015193579A (ja) * | 2014-03-31 | 2015-11-05 | 小林製薬株式会社 | ゼラチンカプセル剤およびその製造方法 |
WO2016084887A1 (ja) * | 2014-11-27 | 2016-06-02 | 大正製薬株式会社 | 水性液体飲料 |
Non-Patent Citations (1)
Title |
---|
VIGNESH, M. ET AL.: ""STABILIZATION OF FOLIC ACID IN LIQUID DOSAGE FORM: FORMULATION DEVELOPMENT, METHOD VALIDATION AND C", INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES, vol. 1, JPN6020002781, 2012, pages 332 - 338, ISSN: 0004288177 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019130499A1 (ja) * | 2017-12-25 | 2019-07-04 | ハウスウェルネスフーズ株式会社 | ビタミンb群化合物の安定性が優れたビタミンb群化合物含有酸性組成物 |
CN108902575A (zh) * | 2018-07-24 | 2018-11-30 | 河北冀衡(集团)药业有限公司 | 饮料及其制备方法 |
CN108902575B (zh) * | 2018-07-24 | 2021-12-28 | 河北冀衡药业股份有限公司 | 饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JP6862108B2 (ja) | 2021-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102770432B (zh) | 还原型吡咯并喹啉醌的制造方法 | |
JPWO2006035900A1 (ja) | コエンザイムq10含有乳化組成物 | |
JPH11503023A (ja) | ビタミンdを含有するカルシウム補給剤およびカルシウム含有飲料 | |
JP6862108B2 (ja) | 葉酸の安定性が優れた葉酸含有酸性組成物 | |
EP2929786A1 (en) | Composition comprising natural polyphenol compounds, and composition for oral administration comprising same | |
US20040077719A1 (en) | Creatine/citric acid compound, method for the production of the same and the use thereof | |
JP2005002005A (ja) | コエンザイムq10含有組成物 | |
JP6762782B2 (ja) | 含有する葉酸の安定性が優れた酸性組成物 | |
US10925845B2 (en) | Stability of vitamin D in β-hydroxy-β-methylbutyrate (HMB) | |
JP7201142B2 (ja) | 葉酸の安定性が優れた葉酸含有酸性組成物 | |
JP7036504B2 (ja) | ビオチンの安定性が優れたビオチン含有酸性組成物 | |
JP3736776B2 (ja) | 新規カルシウム組成物 | |
JP2013192515A (ja) | 牡蠣エキス | |
US20130302448A1 (en) | Phytin aqueous solution and use of said solution for the preparation of a liquid nutritional supplement or a cosmetic composition | |
JP2014207877A (ja) | ウコン中の有用成分を安定的に含有する飲料 | |
JP7036503B2 (ja) | ビタミンb12の安定性が優れたビタミンb12含有酸性組成物 | |
WO2020241374A1 (ja) | ビタミンb12類含有組成物 | |
JP6633896B2 (ja) | ビオチン含有液剤 | |
JP2020196671A (ja) | ビタミンb12類の光安定化方法 | |
WO2019130499A1 (ja) | ビタミンb群化合物の安定性が優れたビタミンb群化合物含有酸性組成物 | |
US20220040205A1 (en) | Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb) | |
JP5849384B2 (ja) | 葉酸含有飲料 | |
JP2013192514A (ja) | 牡蠣エキスの製造方法 | |
JP6323453B2 (ja) | 内服液剤 | |
WO2024175614A1 (en) | Stable liquid formulations comprising (6s)-5-methyltetrahydrofolic acid or salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A625 | Written request for application examination (by other person) |
Free format text: JAPANESE INTERMEDIATE CODE: A625 Effective date: 20190326 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200406 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200623 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200824 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20201027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210126 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210126 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210204 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210209 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210302 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210331 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6862108 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |